文献速递胸部肿瘤放疗放疗物理与技术

小鼠弧形照射立体定向消融肺照射临床前模型:束斑大小与恒定准直下剂量效应

Preclinical Model of Stereotactic Ablative Lung Irradiation Using Arc Delivery in the Mouse: Effect of Beam Size Changes and Dose Effect at Constant Collimation.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2020-04-09

该研究用弧形照射在小鼠左肺建立立体定向消融肺照射临床前模型,比较不同束斑准直器(1 mm、3×3 mm²、7×7 mm²、10×10 mm²)在90 Gy下的束斑效应,以及3×3 mm²准直下20–120 Gy的剂量效应。结果显示仅3 mm束斑准直在90 Gy时产生肺纤维化,恒定3 mm束斑准直下60 Gy为照射后6个月出现肺纤维化的最低剂量。

要点

  • 1 mm与3×3 mm²准直可支持长期研究,但仅3 mm束斑准直在90 Gy时产生肺纤维化。
  • 恒定3 mm束斑准直下,60 Gy为照射后6个月出现肺纤维化的最低剂量。
  • 肺纤维化伴随俱乐部细胞耗竭与II型肺泡上皮细胞增多,并对双侧肺产生影响。

核心结论

  • 弧形照射可支持长期研究及无致死性剂量递增,3×3 mm²准直单次最低60 Gy可在6个月内建立肺损伤临床前模型。

研究设计与样本

  • 使用C57BL/6JRj小鼠左肺90 Gy局灶照射,比较1 mm直径、3×3 mm²、7×7 mm²与10×10 mm²准直器的束斑效应,并以3×3 mm²准直器给予20至120 Gy评估剂量效应。

主要发现

  • 1 mm直径与3×3 mm²准直均允许长期研究,但仅3 mm束斑准直在90 Gy时产生肺纤维化。
  • 恒定3 mm束斑准直的剂量效应研究显示,照射后6个月出现肺纤维化的最低剂量为60 Gy。
  • 肺纤维化发展伴随俱乐部细胞耗竭与II型肺泡上皮细胞数量增加。
  • 肺损伤出现同侧及对侧后果,如肺实质增厚与基因表达改变。

关键数值与推荐

  • 90 Gy局灶照射于左肺,采用1 mm直径、3×3 mm²、7×7 mm²或10×10 mm²准直器评估束斑效应。
  • 3×3 mm²准直器给予20至120 Gy评估剂量效应,60 Gy为6个月出现肺纤维化的最低单次剂量。

临床怎么用

  • 该模型时间跨度与小鼠寿命兼容,可用于机制研究,但结果来自小鼠临床前条件,不能直接外推临床剂量与分割。

局限性

  • 原文摘要未报告样本量、统计方法与具体P值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Stereotactic body radiation therapy is a therapeutic option offered to high surgical risk patients with lung cancer. Focal lung irradiation in mice is a new preclinical model to help understand the development of lung damage in this context. Here we developed a mouse model of lung stereotactic therapy using arc delivery and monitored the development of lung damage while varying the beam size and dose delivered. METHODS AND MATERIALS: C57BL/6JRj mice were exposed to 90 Gy focal irradiation on the left lung using 1-mm diameter, 3 × 3 mm2, 7 × 7 mm2, or 10 × 10 mm2 beam collimation for beam size effect and using 3 × 3 mm2 beam collimation delivering 20 to 120 Gy for dose effect. Long-term lung damage was monitored with micro-computed tomography imaging with anatomopathologic and gene expression measurements in the injured patch and the ipsilateral and contralateral lungs. RESULTS: Both 1-mm diameter and 3 × 3 mm2 beam collimation allow long-term studies, but only 3-mm beam collimation generates lung fibrosis when delivering 90 Gy. Dose-effect studies with constant 3-mm beam collimation revealed a dose of 60 Gy as the minimum to obtain lung fibrosis 6 months postexposure. Lung fibrosis development was associated with club cell depletion and increased type II pneumocyte numbers. Lung injury developed with ipsilateral and contralateral consequences such as parenchymal thickening and gene expression modifications. CONCLUSIONS: Arc therapy allows long-term studies and dose escalation without lethality. In our dose-delivery conditions, dose-effect studies revealed that 3 × 3 mm2 beam collimation to a minimum single dose of 60 Gy enables preclinical models for the assessment of lung injury within a 6-month period. This model of lung tissue fibrosis in a time length compatible with mouse life span may offer good prospects for future mechanistic studies.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Bertho A, Dos Santos M, Buard V, et al. Preclinical Model of Stereotactic Ablative Lung Irradiation Using Arc Delivery in the Mouse: Effect of Beam Size Changes and Dose Effect at Constant Collimation. Int J Radiat Oncol Biol Phys. 2020. PMID: 32278852. doi:10.1016/j.ijrobp.2020.03.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。